CSIMarket
 


Lemaitre Vascular Inc   (LMAT)
Other Ticker:  
 
 

LMAT's Operating Income Growth by Quarter and Year

Lemaitre Vascular Inc 's Operating Income results by quarter and year




LMAT Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 10.21 6.97 8.30 9.55
III Quarter September 9.18 6.15 9.07 10.02
II Quarter June 9.45 5.78 11.11 4.87
I Quarter March 7.87 7.93 7.95 4.35
FY   36.71 26.83 36.43 28.79



LMAT Operating Income fourth quarter 2023 Y/Y Growth Comment
Lemaitre Vascular Inc achieved in the fourth quarter 2023, above Company average Operating Income rise of 46.43% year on year, to $ 10.21 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 26 other companies have achieved higher Operating Income growth. While Lemaitre Vascular Inc ' s Operating Income jump of 46.43% ranks overall at the positon no. 796 in the fourth quarter 2023.

Explain Operating Income growth


LMAT Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 46.43 % -16.02 % -13.09 % 93.71 %
III Quarter September 49.27 % -32.19 % -9.48 % 69.54 %
II Quarter June 63.49 % -47.97 % 128.13 % -17.74 %
I Quarter March -0.76 % -0.25 % 82.76 % -2.03 %
FY   36.81 % -26.35 % 26.54 % 35.8 %

Financial Statements
Lemaitre Vascular Inc 's fourth quarter 2023 Operating Income $ 10.21 millions LMAT's Income Statement
Lemaitre Vascular Inc 's fourth quarter 2022 Operating Income $ 6.97 millions Quarterly LMAT's Income Statement
New: More LMAT's historic Operating Income Growth >>


LMAT Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 11.18 % 13.33 % -8.49 % -4.69 %
III Quarter September -2.86 % 6.4 % -18.36 % 105.75 %
II Quarter June 20.08 % -27.11 % 39.75 % 11.95 %
I Quarter March 12.91 % -4.46 % -16.75 % -11.76 %
FY (Year on Year)   36.81 % -26.35 % 26.54 % 35.8 %




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #60
Overall #796

Operating Income Y/Y Growth Statistics
High Average Low
180.66 % 28.81 % -29.83 %
(March 31, 2015)   (March 31, 2014)
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #60
Overall #796
Operating Income Y/Y Growth Statistics
High Average Low
180.66 % 28.81 % -29.83 %
(March 31, 2015)   (March 31, 2014)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Lemaitre Vascular Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
137.37 % 10.04 % -60.03 %
(Jun 30 2018)  


LMAT's IV. Quarter Q/Q Operating Income Comment
Lemaitre Vascular Inc achieved in the IV. Quarter 2023 above company average sequential Operating Income rise of 11.18%, to $ 10.21 millions, from $9.18 millions in the third quarter.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Lemaitre Vascular Inc 's Operating Income growth quarter on quarter, overall rank is 419.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #38
Overall #419
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #38
Overall #419
Operating Income Q/Q Growth Statistics
High Average Low
137.37 % 10.04 % -60.03 %
(Jun 30 2018)  


LMAT's IV. Quarter Q/Q Operating Income Comment
Lemaitre Vascular Inc achieved in the IV. Quarter 2023 above company average sequential Operating Income rise of 11.18%, to $ 10.21 millions, from $9.18 millions in the third quarter.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Lemaitre Vascular Inc 's Operating Income growth quarter on quarter, overall rank is 419.


Lemaitre Vascular Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ 36.71 $ 33.47 $ 30.44 $ 26.78 $ 26.83
Y / Y Operating Income Growth (TTM) 36.84 % 18.85 % -2.07 % -26.46 % -26.34 %
Year on Year Operating Income Growth Overall Ranking # 1059 # 1054 # 1363 # 903 # 741
Seqeuential Operating Income Change (TTM) 9.68 % 9.95 % 13.7 % -0.2 % -4.74 %
Seq. Operating Income Growth (TTM) Overall Ranking # 796 # 1389 # 1284 # 1191 # 1461




Cumulative Operating Income growth Comment
Lemaitre Vascular Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 36.84% year on year, to $ 37 millions if the fiscal year would have ended in Dec 31 2023.
Lemaitre Vascular Inc 's trailing twelve months Operating Income growth was higher than company's average 28.81% and higher than 18.85% growth in Sep 30 2023.
But sequential rise was slower at 9.68 % from $33.47 millions recorded in twelve months ending a quarter before Luke Scott continued.
We witness stagnation in progress, more noticeable as we look at usual sequential historic rise what is stronger at28.81%.
The momentum was much higher sequentially showed at 9.68 % increase from $33.47 millions in twelve months ending a quarter before.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1054 to 1059.

Operating Income TTM Q/Q Growth Statistics
High Average Low
180.66 %
28.81 %
-29.83 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 82
Overall # 1059

Operating Income TTM Y/Y Growth Statistics
High Average Low
180.66 %
28.81 %
-29.83 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 60
S&P 500 # 796
Cumulative Operating Income growth Comment
Lemaitre Vascular Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 36.84% year on year, to $ 37 millions if the fiscal year would have ended in Dec 31 2023.
Lemaitre Vascular Inc 's trailing twelve months Operating Income growth was higher than company's average 28.81% and higher than 18.85% growth in Sep 30 2023.
But sequential growth rate was slower at 9.68 % from $33.47 millions achieved in twelve months ending a quarter before.
It appears to be stagnation developing, more evident if you pay attention to the average Q/Q TTM historic increase which is stronger at28.81%.
The momentum was even more impressive sequentially exhibited at 9.68 % jump from $33.47 millions in twelve months ending a quarter Sep 30 2023.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1054 to 1059.

Operating Income TTM Q/Q Growth Statistics
High Average Low
180.66 %
28.81 %
-29.83 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 82
Overall # 1059

Operating Income TTM Y/Y Growth Statistics
High Average Low
180.66 %
28.81 %
-29.83 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 60
S&P 500 # 796




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
LMAT's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for LMAT's Competitors
Operating Income Growth for Lemaitre Vascular Inc 's Suppliers
Operating Income Growth for LMAT's Customers

You may also want to know
LMAT's Annual Growth Rates LMAT's Profitability Ratios LMAT's Asset Turnover Ratio LMAT's Dividend Growth
LMAT's Roe LMAT's Valuation Ratios LMAT's Financial Strength Ratios LMAT's Dividend Payout Ratio
LMAT's Roa LMAT's Inventory Turnover Ratio LMAT's Growth Rates LMAT's Dividend Comparisons



Companies with similar Operating Income rise for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Elite Pharmaceuticals Inc 80.32%$ 80.320 millions
Dr Reddy s Laboratories Limited78.66%$ 78.663 millions
Electromed Inc 77.63%$ 77.630 millions
Eli Lilly And Company74.93%$ 74.935 millions
Dexcom Inc 72.97%$ 72.967 millions
Sotera Health Company72.89%$ 72.889 millions
Dariohealth Corp 57.77%$ 57.769 millions
Alcon inc 54.61%$ 54.613 millions
Stryker Corp54.42%$ 54.423 millions
Align Technology inc 52.27%$ 52.267 millions
Davita Inc 52.16%$ 52.158 millions
Healthcare Services Group Inc 51.40%$ 51.399 millions
Tactile Systems Technology Inc 50.32%$ 50.318 millions
Viemed Healthcare Inc 49.66%$ 49.660 millions
United Therapeutics Corporation48.12%$ 48.121 millions
Lemaitre Vascular Inc 46.49%$ 46.491 millions
Neurocrine Biosciences Inc 45.36%$ 45.358 millions
Boston Scientific Corporation45.27%$ 45.274 millions
Msa Safety Incorporated44.79%$ 44.789 millions
Corcept Therapeutics Inc40.76%$ 40.757 millions
Powerup Acquisition Corp 39.00%$ 38.999 millions
Tenet Healthcare Corp37.13%$ 37.127 millions
Chemed Corporation36.97%$ 36.971 millions
Abbott Laboratories36.50%$ 36.503 millions
Nature s Sunshine Products inc 36.49%$ 36.490 millions
Halozyme Therapeutics Inc 35.60%$ 35.601 millions
Catalyst Pharmaceuticals Inc 35.36%$ 35.359 millions
Iqvia Holdings Inc 32.19%$ 32.190 millions
Select Medical Holdings Corp31.53%$ 31.531 millions
Tenax Therapeutics Inc 30.78%$ 30.780 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com